Drug boosts survival in melanoma study
Wednesday, June 9, 2010 - 10:41
in Health & Medicine
Experimental ipilimumab is the first treatment to prolong the lives of those with the deadly skin cancer. The drug, which helps the immune system fight tumors, could be out by the end of the year. Researchers have scored the first big win against melanoma, the deadliest form of skin cancer. An experimental drug significantly improved survival in a major study of people with...